Effect of KATP channel blocker glibenclamide on PACAP38-induced headache and hemodynamic

Early treatment with sumatriptan prevents PACAP38-induced migraine: A randomised clinical trial

(2021) Nita Katarina Frifelt Wienholtz et al.   CEPHALALGIA

Migraine: disease characterisation, biomarkers, and precision medicine

(2021) Messoud Ashina et al.   LANCET

The Effect of KATP Channel Blocker Glibenclamide on CGRP-Induced Headache and Hemodynamic in Healthy Volunteers

(2021) Hande Coskun et al.   Frontiers in Physiology

Effect of Vasoactive Intestinal Polypeptide on Development of Migraine Headaches

(2021) Lanfranco Pellesi et al.   JAMA Network Open

Investigation of sumatriptan and ketorolac trometamol in the human experimental model of headache

(2020) Hashmat Ghanizada et al.   JOURNAL OF HEADACHE AND PAIN

ATP sensitive potassium (KATP) channel inhibition: A promising new drug target for migraine

(2020) Sarah L Christensen et al.   CEPHALALGIA

Two-hour infusion of vasoactive intestinal polypeptide induces delayed headache and extracranial vasodilation in healthy volunteers

(2020) Lanfranco Pellesi et al.   CEPHALALGIA

Effect of KATP channel blocker glibenclamide on levcromakalim-induced headache

(2020) Mohammad Al-Mahdi Al-Karagholi et al.   CEPHALALGIA

Opening of BKCa channels alters cerebral hemodynamic and causes headache in healthy volunteers

(2020) Mohammad Al-Mahdi Al-Karagholi et al.   CEPHALALGIA

A phase 2, randomized, double-blind, placebo-controlled trial of AMG 301, a pituitary adenylate cyclase-activating polypeptide PAC1 receptor monoclonal antibody for migraine prevention

(2020) Messoud Ashina et al.   CEPHALALGIA

Latest Insights into the Pathophysiology of Migraine: the ATP-Sensitive Potassium Channels

(2020) Lili Kokoti et al.   Current Pain and Headache Reports

PACAP-38 and PACAP(6–38) Degranulate Rat Meningeal Mast Cells via the Orphan MrgB3-Receptor

(2019) Sara Hougaard Pedersen et al.   Frontiers in Cellular Neuroscience

PACAP27 induces migraine-like attacks in migraine patients

(2019) Hashmat Ghanizada et al.   CEPHALALGIA

Levcromakalim, an Adenosine Triphosphate‐Sensitive Potassium Channel Opener, Dilates Extracerebral but not Cerebral Arteries

(2019) Mohammad Al‐Mahdi Al‐Karagholi et al.   HEADACHE

Effect of the H1-antihistamine clemastine on PACAP38 induced migraine

(2018) Luise Haulund Vollesen et al.   CEPHALALGIA

PACAP38 in human models of primary headaches

(2017) Håkan Ashina et al.   JOURNAL OF HEADACHE AND PAIN

The KATP channel in migraine pathophysiology: a novel therapeutic target for migraine

(2017) Mohammad Al-Mahdi Al-Karagholi et al.   JOURNAL OF HEADACHE AND PAIN

Investigation of the pathophysiological mechanisms of migraine attacks induced by pituitary adenylate cyclase-activating polypeptide-38

(2014) Faisal Mohammad Amin et al.   BRAIN

Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) Dilates Cerebellar Arteries Through Activation of Large-Conductance Ca2+-Activated (BK) and ATP-Sensitive (KATP) K+ Channels

(2014) Masayo Koide et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

The International Classification of Headache Disorders, 3rd edition (beta version)

(2013)   CEPHALALGIA

A focus on mast cells and pain

(2013) Anne Héron et al.   JOURNAL OF NEUROIMMUNOLOGY

Headache and prolonged dilatation of the middle meningeal artery by PACAP38 in healthy volunteers

(2011) Faisal Mohammad Amin et al.   CEPHALALGIA

Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura

(2010) Jakob Møller Hansen et al.   CEPHALALGIA

Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years after the Discovery

(2009) D. Vaudry et al.   PHARMACOLOGICAL REVIEWS

PACAP38 induces migraine-like attacks in patients with migraine without aura

(2008) Henrik Winther Schytz et al.   BRAIN

Role of KATPChannels in Cephalic Vasodilatation Induced by Calcitonin Gene-Related Peptide, Nitric Oxide, and Transcranial Electrical Stimulation in the Rat

(2008) Aydin Gozalov et al.   HEADACHE